missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novus Biologicals™ Recombinant Human HVEM/TNFRSF14 Fc fusion Protein
Recombinant Protein
Brand: Novus Biologicals™ NBP2-61309-1000ug
This item is not returnable.
View return policy
Description
Fully biologically active when compared to standard. The biologically active as determined by its ability to inhibit TNF-beta -mediated cytotoxicity using murine L929 cells.Specifications
| Bioactivity | |
| 8764 | |
| 1000 μg | |
| Less than 0.1 EU/μg of HVEM/TNFRSF14 as determined by LAL method. | |
| TNFRSF14 | |
| Apoptosis, B Cell Development and Differentiation Markers, Cancer, Immunology | |
| HVEM/TNFRSF14 |
| Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4, 3% Trehalose. | |
| MolecularWeight-theroretical: 58 kDa | |
| Store at -20°C to -70°C as supplied. After reconstitution, store at 2 to 8 C for 1 month and (at -20°C to -70°C for long term storage. Avoid repeated freeze/thaw cycles.) | |
| CD270 antigen, CD40-like protein, Herpes virus entry mediator A, Herpesvirus entry mediator A, HveA, HVEMTR2HVEAATAR, LIGHTR, tumor necrosis factor receptor superfamily member 14, tumor necrosis factor receptor superfamily, member 14 (herpesvirus entrymediator), Tumor necrosis factor receptor-like 2, tumor necrosis factor receptor-like gene2 | |
| Recommended to centrifuge prior to opening. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL Apportion stock solutions into working aliquots and store (at <-20°C.) | |
| >95%, by SDS-PAGE and HPLC |